| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $18.11M | $14.36M | $31.05M | $39.83M | $38.67M |
| SG&A | $17.27M | $16.74M | $15.93M | $15.72M | $12.40M |
| Operating Income | -$62.14M | -$42.10M | -$61.10M | -$59.64M | -$43.07M |
| Interest Expense | – | – | $2.55M | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$63.06M | -$41.52M | -$59.69M | -$58.39M | -$42.85M |
| EPS (basic) | -0.7500 | -0.6700 | -1.3900 | -1.3800 | -1.0200 |
| EPS (diluted) | -0.7500 | -0.6700 | -1.3900 | -1.3800 | -1.0200 |
| Shares (diluted) | – | – | – | – | – |